Download PDF
Int J Angiol 2019; 28(04): 226-230
DOI: 10.1055/s-0039-1695049
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Stroke Complicating Acute ST Elevation Myocardial Infarction—Current Concepts

Monika Bhandari
1   Department of Cardiology, King George's Medical University, Lucknow, India
,
Pravesh Vishwakarma
1   Department of Cardiology, King George's Medical University, Lucknow, India
,
Rishi Sethi
1   Department of Cardiology, King George's Medical University, Lucknow, India
,
Akshyaya Pradhan 
1   Department of Cardiology, King George's Medical University, Lucknow, India
› Author Affiliations
Further Information

Publication History

Publication Date:
20 September 2019 (online)

    Permissions and Reprints

Abstract

Myocardial infarction (MI) is one of the leading causes of mortality today both in developed and developing countries alike. Advancement in the pharmacotherapy and revascularization techniques has resulted in drastic improvement in survival. Most of the complications of MI can be managed adequately resulting in reduced mortality from MI in the recent years. However, mortality from stroke following acute MI remains high even today. Here, we discuss the incidence, risk factors, and management of stroke following acute ST elevation MI.

Keywords

ischemic stroke - thrombolysis - CT scan - reperfusion therapy
 

  • References

  • 1 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
    PubMed
  • 2 Weaver WD, Simes RJ, Betriu A. , et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA 1997; 278 (23) 2093-2098
    CrossrefPubMedGoogle Scholar
  • 3 Nallamothu BK, Bates ER. Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything?. Am J Cardiol 2003; 92 (07) 824-826
    CrossrefPubMedGoogle Scholar
  • 4 Betriu A, Masotti M. Comparison of mortality rates in acute myocardial infarction treated by percutaneous coronary intervention versus fibrinolysis. Am J Cardiol 2005; 95 (01) 100-101
    CrossrefPubMedGoogle Scholar
  • 5 Boersma E. ; Primary Coronary Angioplasty vs. Thrombolysis Group. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J 2006; 27 (07) 779-788
    CrossrefPubMedGoogle Scholar
  • 6 Pinto DS, Kirtane AJ, Nallamothu BK. , et al. Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy. Circulation 2006; 114 (19) 2019-2025
    CrossrefPubMedGoogle Scholar
  • 7 Pinto DS, Frederick PD, Chakrabarti AK. , et al; National Registry of Myocardial Infarction Investigators. Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase. Circulation 2011; 124 (23) 2512-2521
    CrossrefPubMedGoogle Scholar
  • 8 Cantor WJ, Fitchett D, Borgundvaag B. , et al; TRANSFER-AMI Trial Investigators. Routine early angioplasty after fibrinolysis for acute myocardial infarction. N Engl J Med 2009; 360 (26) 2705-2718
    CrossrefPubMedGoogle Scholar
  • 9 Armstrong PW, Gershlick AH, Goldstein P. , et al; STREAM Investigative Team. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N Engl J Med 2013; 368 (15) 1379-1387
    CrossrefPubMedGoogle Scholar
  • 10 Rashid MK, Guron N, Bernick J. , et al. Safety and efficacy of a pharmacoinvasive strategy in ST-segment elevation myocardial infarction: a patient population study comparing a pharmacoinvasive strategy with a primary percutaneous coronary intervention strategy within a regional system. JACC Cardiovasc Interv 2016; 9 (19) 2014-2020
    CrossrefPubMedGoogle Scholar
  • 11 Sim DS, Jeong MH, Ahn Y. , et al; Korea Acute Myocardial Infarction Registry (KAMIR) Investigators. Pharmacoinvasive strategy versus primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction: a propensity score-matched analysis. Circ Cardiovasc Interv 2016; 9 (09) e003508
    PubMedGoogle Scholar
  • 12 Tanne D, Gottlieb S, Hod H, Reicher-Reiss H, Boyko V, Behar S. ; Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) and Israeli Thrombolytic Survey Groups. Incidence and mortality from early stroke associated with acute myocardial infarction in the prethrombolytic and thrombolytic eras. J Am Coll Cardiol 1997; 30 (06) 1484-1490
    CrossrefPubMedGoogle Scholar
  • 13 Komrad MS, Coffey CE, Coffey KS, McKinnis R, Massey EW, Califf RM. Myocardial infarction and stroke. Neurology 1984; 34 (11) 1403-1409
    CrossrefPubMedGoogle Scholar
  • 14 Thompson PL, Robinson JS. Stroke after acute myocardial infarction: relation to infarct size. BMJ 1978; 2 (6135): 457-459
    CrossrefPubMedGoogle Scholar
  • 15 Al Suwaidi J, Al Habib K, Asaad N. , et al. Immediate and one-year outcome of patients presenting with acute coronary syndrome complicated by stroke: findings from the 2nd Gulf Registry of Acute Coronary Events (Gulf RACE-2). BMC Cardiovasc Disord 2012; 12: 64
    CrossrefPubMedGoogle Scholar
  • 16 Longstreth Jr WT, Litwin PE, Weaver WD. ; The MITI Project Group. Myocardial infarction, thrombolytic therapy, and stroke. A community-based study. Stroke 1993; 24 (04) 587-590
    CrossrefPubMedGoogle Scholar
  • 17 Kajermo U, Ulvenstam A, Modica A, Jernberg T, Mooe T. Incidence, trends, and predictors of ischemic stroke 30 days after an acute myocardial infarction. Stroke 2014; 45 (05) 1324-1330
    CrossrefPubMedGoogle Scholar
  • 18 Mooe T, Olofsson BO, Stegmayr B, Eriksson P. Ischemic stroke. Impact of a recent myocardial infarction. Stroke 1999; 30 (05) 997-1001
    CrossrefPubMedGoogle Scholar
  • 19 Brammås A, Jakobsson S, Ulvenstam A, Mooe T. Mortality after ischemic stroke in patients with acute myocardial infarction: predictors and trends over time in Sweden. Stroke 2013; 44 (11) 3050-3055
    CrossrefPubMedGoogle Scholar
  • 20 Binsell-Gerdin E, Graipe A, Ögren J, Jernberg T, Mooe T. Hemorrhagic stroke the first 30 days after an acute myocardial infarction: incidence, time trends and predictors of risk. Int J Cardiol 2014; 176 (01) 133-138
    CrossrefPubMedGoogle Scholar
  • 21 Giugliano RP, Giraldez RR, Morrow DA. , et al. Relations between bleeding and outcomes in patients with ST-elevation myocardial infarction in the ExTRACT-TIMI 25 trial. Eur Heart J 2010; 31 (17) 2103-2110
    CrossrefPubMedGoogle Scholar
  • 22 Witt BJ, Brown Jr RD, Jacobsen SJ, Weston SA, Yawn BP, Roger VL. A community-based study of stroke incidence after myocardial infarction. Ann Intern Med 2005; 143 (11) 785-792
    PubMedGoogle Scholar
  • 23 Lichtman JH, Krumholz HM, Wang Y, Radford MJ, Brass LM. Risk and predictors of stroke after myocardial infarction among the elderly: results from the Cooperative Cardiovascular Project. Circulation 2002; 105 (09) 1082-1087
    CrossrefPubMedGoogle Scholar
  • 24 Mahaffey KW, Granger CB, Sloan MA. , et al. Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-I. Circulation 1998; 97 (08) 757-764
    CrossrefPubMedGoogle Scholar
  • 25 Powers WJ, Rabinstein AA, Ackerson T. , et al; American Heart Association Stroke Council. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2018; 49 (03) e46-e110
    CrossrefPubMedGoogle Scholar
  • 26 Omar HR, Mangar D, Camporesi EM. Simultaneous thrombosis of 2 vascular territories: is thrombolytic therapy a better option?. Am J Emerg Med 2013; 31 (09) 1412-1413
    PubMedGoogle Scholar
  • 27 Demaerschalk BM, Kleindorfer DO, Adeoye OM. , et al; American Heart Association Stroke Council and Council on Epidemiology and Prevention. Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2016; 47 (02) 581-641
    CrossrefPubMedGoogle Scholar
  • 28 Brouwers HB, Greenberg SM. Hematoma expansion following acute intracerebral hemorrhage. Cerebrovasc Dis 2013; 35 (03) 195-201
    CrossrefPubMedGoogle Scholar
  • 29 Anderson CS, Heeley E, Huang Y. , et al; INTERACT2 Investigators. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med 2013; 368 (25) 2355-2365
    CrossrefPubMedGoogle Scholar
  • 30 Morgenstern LB, Hemophill III JC, Aderson C. , et al.; on behalf of the American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, and Council on Clinical Cardiology. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2015; 46: 2032-2060
    CrossrefPubMedGoogle Scholar
  • 31 Hemphill III JC, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 2001; 32 (04) 891-897
    CrossrefPubMedGoogle Scholar
  • 32 Maggioni AP, Franzosi MG, Santoro E. , et al. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group. N Engl J Med 1992; 327: 1-6
    CrossrefPubMedGoogle Scholar